BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19694314)

  • 21. Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach.
    Tosi GM; Trimarchi C; Macaluso M; La Sala D; Ciccodicola A; Lazzi S; Massaro-Giordano M; Caporossi A; Giordano A; Cinti C
    Oncogene; 2005 Sep; 24(38):5827-36. PubMed ID: 16007224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma.
    Ben Nasr H; Chahed K; Mestiri S; Bouaouina N; Snoussi K; Chouchane L
    Hum Immunol; 2007 Sep; 68(9):761-9. PubMed ID: 17869651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation of Epstein-Barr virus A73 gene polymorphisms to susceptibility to nasopharyngeal carcinoma].
    Zhang LL; Li DJ; Li ZH; Zhang XS; Zhang RH; Yu XJ; Chen LZ; Feng QS; Zeng YX; Jia WH
    Ai Zheng; 2007 Oct; 26(10):1047-51. PubMed ID: 17927871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pRb2/p130: a new candidate for retinoblastoma tumor formation.
    De Falco G; Giordano A
    Oncogene; 2006 Aug; 25(38):5333-40. PubMed ID: 16936755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 and nasopharyngeal carcinoma: a Malaysian study.
    Hoe SL; Lee ES; Khoo AS; Peh SC
    Pathology; 2009; 41(6):561-5. PubMed ID: 19900105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
    Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma.
    Jiang RC; Qin HD; Zeng MS; Huang W; Feng BJ; Zhang F; Chen HK; Jia WH; Chen LZ; Feng QS; Zhang RH; Yu XJ; Zheng MZ; Zeng YX
    Cancer Res; 2006 Jan; 66(2):693-700. PubMed ID: 16423998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A molecular study of first and second RB1 mutational hits in retinoblastoma patients.
    de Andrade AF; da Hora Barbosa R; Vargas FR; Ferman S; Eisenberg AL; Fernandes L; Bonvicino CR
    Cancer Genet Cytogenet; 2006 May; 167(1):43-6. PubMed ID: 16682285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic instability in the progression of sporadic nasopharyngeal carcinoma.
    Tan G; Chu Y; Chen J; Li H
    Otolaryngol Head Neck Surg; 2006 Jan; 134(1):147-52. PubMed ID: 16399196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [No point mutation of the 2.8 kb EcORI fragment of the nasopharyngeal carcinoma transforming gene TX in nasopharyngeal carcinoma].
    Deng X; Cao Y; Hu W; Gu H; Yao K
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):102-4. PubMed ID: 9868046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma.
    Gao LB; Liang WB; Xue H; Rao L; Pan XM; Lv ML; Bai P; Fang WL; Liu J; Liao M; Zhang L
    Clin Chim Acta; 2009 Nov; 409(1-2):132-5. PubMed ID: 19758567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The detection of Rb2/p130 and p53 gene mutations by denaturing high-performance liquid chromatography analysis of sputum of lung cancer patients and its clinical implications].
    Wang BC; Li LY; Cheng SJ; Gao YN
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):499-501. PubMed ID: 15312402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genomic instability in nasopharyngeal carcinoma].
    Li HQ; Zhu YM; Chen JB; Tan GL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):417-21. PubMed ID: 17611317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis.
    Lazzi S; Bellan C; De Falco G; Cinti C; Ferrari F; Nyongo A; Claudio PP; Tosi GM; Vatti R; Gloghini A; Carbone A; Giordano A; Leoncini L; Tosi P
    Hum Pathol; 2002 Jul; 33(7):723-31. PubMed ID: 12196924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of caspase-14 gene in common carcinomas.
    Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
    Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHFR gene is neither mutated nor hypermethylated in ovarian cancer.
    Ludwig AH; Bujko M; Bidzinski M; KupryjaƄczyk J
    Cancer Detect Prev; 2007; 31(3):257-61. PubMed ID: 17673375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic structure of the human retinoblastoma-related Rb2/p130 gene.
    Baldi A; Boccia V; Claudio PP; De Luca A; Giordano A
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4629-32. PubMed ID: 8643454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.
    Sun Y; Hegamyer G; Cheng YJ; Hildesheim A; Chen JY; Chen IH; Cao Y; Yao KT; Colburn NH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6516-20. PubMed ID: 1631151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RB2/p130 gene: the latest weapon in the war against lung cancer?
    Claudio PP; Caputi M; Giordano A
    Clin Cancer Res; 2000 Mar; 6(3):754-64. PubMed ID: 10741694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligonucleotide probe array for p53 gene alteration analysis in DNA from formalin-fixed paraffin-embedded breast cancer tissues.
    Lumachi F; Marino F; Varotto S; Basso U
    Ann N Y Acad Sci; 2009 Sep; 1175():89-92. PubMed ID: 19796081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.